MONACO, ILENIA
 Distribuzione geografica
Continente #
EU - Europa 298
NA - Nord America 204
AS - Asia 42
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 546
Nazione #
US - Stati Uniti d'America 204
IE - Irlanda 105
SE - Svezia 67
UA - Ucraina 64
CN - Cina 39
AT - Austria 34
IT - Italia 21
FR - Francia 3
IN - India 3
DE - Germania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
GB - Regno Unito 1
RU - Federazione Russa 1
Totale 546
Città #
Dublin 105
Nyköping 45
Jacksonville 37
Vienna 34
Chandler 30
Ashburn 24
New York 14
Nanjing 11
Princeton 11
Beijing 9
Wilmington 7
Gesualdo 6
Dearborn 4
Nanchang 4
Woodbridge 4
Pune 3
Rome 3
Seattle 3
Acerra 2
Apricena 2
Changchun 2
Des Moines 2
Foggia 2
Hanover 2
Jiaxing 2
Martina Franca 2
Philadelphia 2
Shenyang 2
Tianjin 2
Aprilia 1
Augusta 1
Borås 1
Changsha 1
Chengdu 1
Hangzhou 1
Hebei 1
Hubert 1
Jackson 1
Jinan 1
Kilcoy 1
Leawood 1
Los Angeles 1
Norwalk 1
Novokuznetsk 1
Palermo 1
Porto 1
Redwood City 1
San Mateo 1
Shanghai 1
Stevenage 1
Xian 1
Totale 398
Nome #
Cardiopulmonary exercise test predicts right heart catheterization 76
Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability 72
Redefining biomarkers in heart failure 66
Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia 65
Echocardiographic score for prediction of pulmonary hypertension at catheterization: The Daunia Heart Failure Registry 52
Advanced heart failure: non-pharmacological approach 49
Novel AKAP9 mutation and long QT syndrome in a patient with torsades des pointes 49
Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry 43
Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure 43
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: Where do we stand? 42
Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization 35
Totale 592
Categoria #
all - tutte 3.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 5 8
2019/202070 12 4 1 0 4 3 16 1 12 6 11 0
2020/202191 11 7 10 3 10 0 11 14 11 14 0 0
2021/202269 1 0 0 0 9 1 3 6 10 19 0 20
2022/2023220 20 14 15 5 3 18 0 13 115 0 6 11
2023/202463 15 2 0 1 9 22 0 13 0 1 0 0
Totale 592